Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option

Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option ranks among the stronger performers in the Index Funds category, backed by a 5-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 87/100.

Cost: At 0.47%, the expense ratio runs 15% above the Index Funds category average of 0.41%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.29 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 14.46% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to cost-conscious investors happy to simply match the market rather than try to beat it. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.